Literature DB >> 21300179

Data withdrawal in randomized controlled trials: Defining the problem and proposing solutions: a commentary.

Chenglin Ye1, Lora Giangregorio, Anne Holbrook, Eleanor Pullenayegum, Charlie H Goldsmith, Lehana Thabane.   

Abstract

It is not uncommon for a participant to withdraw from a randomized controlled trial (RCT). The withdrawal of a participant results in missing data and the potential for withdrawal bias. Data withdrawal, or a request from a participant to withdraw all of their previously collected data from a study, is particularly problematic because it leaves little opportunity to characterize or statistically address those that have withdrawn to minimize withdrawal bias. The aim of this commentary is to (1) provide a synthesis of available information on the ethical and methodological issues related to data withdrawal in RCTs and (2) provide some suggestions on how to minimize the impact of data withdrawal during the execution or analysis phases of an RCT. We searched PubMed, EMBASE and JSTOR for published articles on data withdrawal. In addition, we used internet sources as an additional tool to identify content on data withdrawal from research ethics guidelines, legislation, research ethics boards, funding agencies, professional organizations and researchers. We did not find any definitive guidelines for dealing with data withdrawal. We propose recommendations for minimizing the occurrence of data withdrawal, including explicit and clear descriptions in consent forms of how data will be handled after participant withdrawal. We also suggest using imputation techniques to deal with the missing data during analysis. The current commentary can be used to minimize the impact of data withdrawal in RCTs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21300179     DOI: 10.1016/j.cct.2011.01.016

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  10 in total

1.  Withdrawal from biobank research: considerations and the way forward.

Authors:  Kristina Hug; Göran Hermerén; Mats Johansson
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

2.  Data retention after a patient withdraws consent in clinical trials.

Authors:  André P Gabriel; Charles P Mercado
Journal:  Open Access J Clin Trials       Date:  2011-04

3.  Parental decision making regarding consent to randomization on Children's Oncology Group AALL0932.

Authors:  Kellee Parker; Erika Cottrell; Linda Stork; Susan Lindemulder
Journal:  Pediatr Blood Cancer       Date:  2021-01-26       Impact factor: 3.167

4.  A tutorial on sensitivity analyses in clinical trials: the what, why, when and how.

Authors:  Lehana Thabane; Lawrence Mbuagbaw; Shiyuan Zhang; Zainab Samaan; Maura Marcucci; Chenglin Ye; Marroon Thabane; Lora Giangregorio; Brittany Dennis; Daisy Kosa; Victoria Borg Debono; Rejane Dillenburg; Vincent Fruci; Monica Bawor; Juneyoung Lee; George Wells; Charles H Goldsmith
Journal:  BMC Med Res Methodol       Date:  2013-07-16       Impact factor: 4.615

5.  Enhancing research publications and advancing scientific writing in health research collaborations: sharing lessons learnt from the trenches.

Authors:  Guowei Li; Yanling Jin; Lawrence Mbuagbaw; Lisa Dolovich; Jonathan D Adachi; Mitchell Ah Levine; Deborah Cook; Zainab Samaan; Lehana Thabane
Journal:  J Multidiscip Healthc       Date:  2018-05-17

6.  Study Protocol: The Coaching Alternative Parenting Strategies (CAPS) Study of Parent-Child Interaction Therapy in Child Welfare Families.

Authors:  Akhila K Nekkanti; Rose Jeffries; Carolyn M Scholtes; Lisa Shimomaeda; Kathleen DeBow; Jessica Norman Wells; Emma R Lyons; Ryan J Giuliano; Felicia J Gutierrez; Kyndl X Woodlee; Beverly W Funderburk; Elizabeth A Skowron
Journal:  Front Psychiatry       Date:  2020-09-02       Impact factor: 5.435

7.  Effects of one-year once-weekly high-intensity interval training on body adiposity and liver fat in adults with central obesity: Study protocol for a randomized controlled trial.

Authors:  Edwin C Chin; Chit K Leung; Danny J Yu; Angus P Yu; Joshua K Bernal; Christopher W Lai; Derwin K C Chan; Heidi H Ngai; Patrick S H Yung; Chi H Lee; Daniel Y Fong; Shelley E Keating; Jeff S Coombes; Parco M Siu
Journal:  J Exerc Sci Fit       Date:  2022-03-14       Impact factor: 3.103

8.  Cancer patient perceptions on the ethical and legal issues related to biobanking.

Authors:  Zubin Master; Jaime O Claudio; Christen Rachul; Jean C Y Wang; Mark D Minden; Timothy Caulfield
Journal:  BMC Med Genomics       Date:  2013-03-08       Impact factor: 3.063

9.  Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study.

Authors:  Chenglin Ye; Joseph Beyene; Gina Browne; Lehana Thabane
Journal:  BMJ Open       Date:  2014-06-17       Impact factor: 2.692

Review 10.  The role of ethics in data governance of large neuro-ICT projects.

Authors:  Bernd Carsten Stahl; Stephen Rainey; Emma Harris; B Tyr Fothergill
Journal:  J Am Med Inform Assoc       Date:  2018-08-01       Impact factor: 4.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.